600420 Shanghai Shyndec Pharmaceutical
- 12.26
- -0.43-3.39%
Shanghai Shyndec Pharmaceutical News
Announcement on the holding subsidiary obtaining a drug registration certificate
Announcement on the wholly-owned subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Announcement on the holding subsidiary obtaining a drug registration certificate
Voluntary Information Disclosure Notice on Wholly Owned Subsidiary Drugs Passing the Generic Drug Consistency Evaluation
Announcement on preparation for depreciation
Sinopharm Hyundai: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Sinopharm Hyundai: Legal Opinion on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Hyundai Pharmaceutical Co., Ltd.
Legal Opinion on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Modern Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Announcement on the wholly-owned subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Meeting materials of the 2024 First Extraordinary General Meeting of Shareholders
Notice on Obtaining a Notice of Approval for Drug Supplementation Applications
Notice on the holding subsidiary receiving a notice of approval for the drug supplement application
Notice on wholly-owned subsidiaries obtaining drug registration certificates
Announcement on the holding subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Report on the 2024 semi-annual risk continuity assessment of Sinopharm Group Finance Co., Ltd.
Voluntary Information Disclosure Announcement Regarding Pharmaceutical Subsidiary's Consistent Evaluation of Generic Drugs
Announcement Regarding Holding Subsidiary Pharmaceutical Passed Generic Drug Consistency Evaluation
No Data
